CHICAGO and TEL AVIV, ISRAL, September 30, 2021 / PRNewswire / – UltraSight, a Digital Health Pioneer Transforming Heart Imaging Using the Power of AI, Announced New Collaboration with GE Healthcare to Conduct Heart Study Aboard the Axiom “Rakia” Space Mission , and the successful completion of the preliminary design examination (PDR) for point-of-care cardiac ultrasound (POCUS). During the study, UltraSight’s real-time AI guidance software and GE Healthcare’s GE Vscan Air handheld™, the high-performance wireless pocket-size color ultrasound, will record images of an astronaut’s heart in microgravity.
The aim of this study is to demonstrate how, using the right technology, accurate cardiac ultrasound images can be acquired anywhere – even in space – and how AI guidance has the potential to enable successful digitization with limited training. During the mission, Lt. Col. Eytan Stibbe, Israel’s first flight to the International Space Station, will use Vscan Air™ ultrasound device with UltraSight AI guidance and take its own heart images, independent of trained healthcare professionals or ground mission control. The results of this study could potentially benefit millions of cardiology patients around the world, especially in underserved communities where access to echocardiography laboratories and large medical systems is limited.
“Easy access to cardiac diagnostic imaging and a small, durable wireless ultrasound device that can operate in difficult space conditions would be extremely important – it could help monitor the health of space crews and provide critical information on whether or not immediate intervention is necessary. ” noted Davidi vortman, CEO of UltraSight. “Vscan Air™ does the trick. We are excited to partner with GE Healthcare and lead a new wave of medical innovation in space. “
“Space agencies are looking for an ultrasound solution with the functionality provided by GE Healthcare and UltraSight, not only for the International Space Station, but also to support upcoming missions, including Artemis to the Moon and soon after to Mars. noted Eran Schenker, MD, Medical Director of Innovation, Israel Institute of Aerospace Medicine (IAMI). “In fact, the mission to Mars, which will have communication problems and significant delays, will require rethinking telemedicine. Real-time guidance from the AI will be essential to allow the crew to obtain cardiac images without relying on mission control on Earth. he concluded.
GE Healthcare launched the first pocket-sized color ultrasound machine, Vscan, in 2010 and has since continued to revolutionize the way clinicians use portable ultrasound to view patients. To date, there are over 30,000 Vscan Family systems in the pockets of clinicians, impacting the care of over 50 million patients worldwide. The Vscan Air™, launched earlier this year, increases access to accurate care, helping to improve workflow efficiency and patient outcomes with dual-probe full-body scanning capabilities and a user-friendly interface.
“The upcoming space mission aims to demonstrate the added value AI could have for point-of-care ultrasound by providing flexible and rapid access to diagnostic information anywhere and anytime,” said James hurley, general manager of portable ultrasound at GE Healthcare. “From the farthest place you can imagine, which is space, to primary and acute care facilities in local communities around the world, this technology plays a vital role in providing patients with accurate and rapid diagnosis of heart ailments and other illnesses.“
The “Rakia” preliminary design review was completed after the technology was presented to the Science Program Committee, the Israel Space Authority, the Ramon Foundation and Colonel Stibbe. Its successful completion is a key step in the process of any space mission project, as it identifies potential issues and ensures that the design will help meet all space mission requirements.
After meeting the UltraSight medical team and learning about the technology, Col. Stibbe said, “I am happy to play a role in testing medical innovations that can improve patient access to advanced medical care around the world. Even in 2021 as well. many people still do not have access to advanced health care. It is a step in the right direction. “
In May 2021, UltraSight has been selected by the Israel Space Agency to conduct the cardiac study aboard the “Rakia” space mission. The company chose GE Healthcare as a partner because of its R&D expertise and the high image quality of the Vscan Air™.
UltraSight is a partner in GE Healthcare’s Edison ™ Development Program, a dynamic ecosystem that helps innovators deliver advanced healthcare applications, integrate products and drive business growth.
This is not the first time that a GE Healthcare ultrasound machine has been used in space. In july 2011, Vivid from GE Healthcare™ q a cardiovascular ultrasound system was delivered to the International Space Station (ISS) during the last flight of the space shuttle Atlantis.
For more information on UltraSight and GE Healthcare’s involvement in the upcoming ‘Rakia’ space mission, contact Moon Newton at [email protected]
* UltraSight AI guidance software is currently pending approval for medical use in the US and European markets.
UltraSight aims to revolutionize cardiac ultrasound using the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system and advanced user functionality help bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients to access ultrasound anywhere. or. In 2020, UltraSight won the TCT Innovation Competition, which was held at the Transcatheter Cardiovascular Therapeutics Global Conference. For more news and information, visit our website or follow UltraSight on LinkedIn and Twitter.
About GE Healthcare
GE Healthcare is the $ 18 billion GE healthcare business. As a leading global innovator in medical technology, pharmaceutical diagnostics and digital solutions, GE Healthcare enables clinicians to make faster, more informed decisions through smart devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of experience in the healthcare industry and approximately 47,000 employees worldwide, the company operates at the center of an ecosystem that works for precision health, digitizes healthcare, helps increase productivity and improve outcomes for patients, providers, health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, and Insights for the latest news, or visit our website www.gehealthcare.com for more information.
View original content: https://www.prnewswire.com/news-releases/ultrasight-collaboration-with-ge-healthcare-will-bring-wireless-cardiac-point-of-care-ultrasound-to-space-301388585 . html